- Home
- REKR vs PRQR Comparison
REKR vs PRQR Comparison
Compare REKR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- PRQR
- Stock Information
- Founded
- REKR 2017
- PRQR 2012
- Country
- REKR United States
- PRQR Netherlands
- Employees
- REKR N/A
- PRQR N/A
- Industry
- REKR Telecommunications Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- PRQR Health Care
- Exchange
- REKR Nasdaq
- PRQR Nasdaq
- Market Cap
- REKR 153.5M
- PRQR 179.1M
- IPO Year
- REKR N/A
- PRQR 2014
- Fundamental
- Price
- REKR $1.11
- PRQR $2.03
- Analyst Decision
- REKR
- PRQR Strong Buy
- Analyst Count
- REKR 0
- PRQR 8
- Target Price
- REKR N/A
- PRQR $8.88
- AVG Volume (30 Days)
- REKR 7.0M
- PRQR 353.7K
- Earning Date
- REKR 08-13-2025
- PRQR 08-07-2025
- Dividend Yield
- REKR N/A
- PRQR N/A
- EPS Growth
- REKR N/A
- PRQR N/A
- EPS
- REKR N/A
- PRQR N/A
- Revenue
- REKR $45,448,000.00
- PRQR $21,212,711.00
- Revenue This Year
- REKR $8.68
- PRQR N/A
- Revenue Next Year
- REKR $21.45
- PRQR N/A
- P/E Ratio
- REKR N/A
- PRQR N/A
- Revenue Growth
- REKR 17.97
- PRQR 85.91
- 52 Week Low
- REKR $0.62
- PRQR $1.07
- 52 Week High
- REKR $2.67
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- REKR 47.43
- PRQR 62.61
- Support Level
- REKR $1.08
- PRQR $2.00
- Resistance Level
- REKR $1.50
- PRQR $2.54
- Average True Range (ATR)
- REKR 0.09
- PRQR 0.13
- MACD
- REKR -0.02
- PRQR 0.01
- Stochastic Oscillator
- REKR 19.05
- PRQR 37.33
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.